» Articles » PMID: 35384966

Low Concordance Between NYHA Classification and Cardiopulmonary Exercise Test Variables in Patients with Heart Failure and Reduced Ejection Fraction

Abstract

Background: The New York Heart Association (NYHA) functional classification is the most commonly used classification system for heart failure (HF), whereas cardiopulmonary exercise testing (CPET) is the gold standard for functional status evaluation in HF.

Objective: This study aimed to analyze correlation and concordance between NYHA classes and CPET variables.

Methods: HF patients with clinical indication for CPET and ejection fraction (EF) < 50% were selected. Correlation (Spearman coefficient) and concordance (kappa) between NYHA classification and CPET-based classifications were analyzed. A p < 0.05 was accepted as significant.

Results: In total, 244 patients were included. Mean age was 56 ± 14 years, and mean EF was 35.5% ± 10%. Distribution of patients according to NYHA classification was 31.2%% class I, 48.3% class II, 19.2% class III, and 1.3% class IV. Correlation (r) between NYHA and Weber classes was 0.489 (p < 0.001), and concordance was 0.231 (p < 0.001). Correlation (r) between NYHA and ventilatory classes (minute ventilation/carbon dioxide production [VE/VCO2] slope) was 0.218 (p < 0.001), and concordance was 0.002 (p = 0.959). Spearman correlation between NYHA and CPET score classes was 0.223 (p = 0.004), and kappa concordance was 0.027 (p = 0.606).

Conclusion: There was a moderate association between NYHA and Weber classes, although concordance was low. Ventilatory (VE/VCO2slope) and CPET score classes had a weak association and a low concordance with NYHA classes.

Citing Articles

Incremental Role of New York Heart Association Class and Cardiopulmonary Exercise Test Indices for Prognostication in Heart Failure: A Cohort Study.

Engster P, Zimerman A, Schaan T, Borges M, Souza G, Costa G Arq Bras Cardiol. 2023; 120(11):e20230077.

PMID: 38126514 PMC: 10773458. DOI: 10.36660/abc.20230077.


NYHA Classification and Cardiopulmonary Exercise Test Variables in Patients with Heart Failure.

Costa R Arq Bras Cardiol. 2022; 118(6):1124-1125.

PMID: 35703650 PMC: 9345164. DOI: 10.36660/abc.20220196.

References
1.
Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed). 2016; 69(12):1167. DOI: 10.1016/j.rec.2016.11.005. View

2.
Balady G, Arena R, Sietsema K, Myers J, Coke L, Fletcher G . Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010; 122(2):191-225. DOI: 10.1161/CIR.0b013e3181e52e69. View

3.
Guimaraes G, Vaz da Silva M, Moraes DAvila V, Ferreira S, Silva C, Bocchi E . Peak VO2 and VE/VCO2 slope in betablockers era in patients with heart failure: a Brazilian experience. Arq Bras Cardiol. 2008; 91(1):39-48. DOI: 10.1590/s0066-782x2008001300007. View

4.
Myers J, Oliveira R, Dewey F, Arena R, Guazzi M, Chase P . Validation of a cardiopulmonary exercise test score in heart failure. Circ Heart Fail. 2013; 6(2):211-8. PMC: 7233377. DOI: 10.1161/CIRCHEARTFAILURE.112.000073. View

5.
Lim F, Yap J, Gao F, Teo L, Lam C, Yeo K . Correlation of the New York Heart Association classification and the cardiopulmonary exercise test: A systematic review. Int J Cardiol. 2018; 263:88-93. DOI: 10.1016/j.ijcard.2018.04.021. View